Dublin, March 15, 2024 (GLOBE NEWSWIRE) -- The "Coagulation Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global Coagulation Testing market is currently witnessing significant growth, with an anticipated surge from US$3.1 Billion in 2022 to a projected US$4.5 Billion by the year 2030. This promising outlook presents a compound annual growth rate (CAGR) of 4.8% during the analysis period of 2022-2030.
Remarkable Growth Foreseen in Consumables and Instruments
Within this market, the Consumables segment is projected to achieve a robust CAGR of 5.1%, anticipated to reach a staggering US$3.7 Billion by the conclusion of the analysis period. In tandem, growth predictions for the Instruments segment have been adjusted to a respectable 3.6% CAGR across the next eight years, highlighting the sector's enduring vitality in a post-pandemic landscape.
Geographic Market Analysis Indicating Strong U.S. and China Performance
The U.S. is estimated to command a significant market valuation of US$828.7 Million in 2022, while China showcases a vibrant 7.4% CAGR, heralding a projected market size of US$990 Million by 2030. This illustrates China's dynamic pace as the globe's second-largest economy. Other noteworthy geographic markets include Japan and Canada, which are predicted to expand at CAGRs of 2.6% and 4.5%, respectively. Additionally, Europe's market, led by Germany, is expected to grow at a CAGR of around 2.8%.
Market Players and Innovation
- Market presence and competitive dynamics are shaped by prominent players, featuring innovative product portfolios and strategic regional footprints.
- More than 38 key competitors have been featured, signifying a diverse and competitive landscape.
The analysis also incorporates a special coverage focusing on current global events such as the geopolitical implications of the Russia-Ukraine conflict, challenges stemming from global inflation, and the anticipated impact of China's policies on market dynamics. Furthermore, it assesses the influence of supply chain disruptions, international trade disputes, and the potential risks associated with an economic recession on the Coagulation Testing market.
What's Newly Included?
- In-depth coverage of pressing global challenges and their market implications.
- An examination of market presence and dominance across diverse geographies, ranging from strong and active to niche and trivial market participations.
- Access to collaborative online updates and digital data archives, elevating the research experience.
- Beneficial one-year complimentary updates for existing observations.
These findings emanate from the latest strategic business report highlighting the Coagulation Testing market's evolution, encompassing crucial analytical insights for industry stakeholders, practitioners, and investors seeking informed decision-making and a clear understanding of market trajectories.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 171 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $3.1 Billion |
| Forecasted Market Value (USD) by 2030 | $4.5 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Coveed | Global |
A selection of companies mentioned in this report includes
- Abbott Laboratories, Inc.
- Agappe Diagnostics Ltd.
- Alere, Inc.
- F. Hoffmann-La Roche AG
- Helena Laboratories, Inc.
- HemoSonics, LLC
- Horiba, Ltd.
- Medtronic PLC
- Randox Laboratories Ltd.
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
- Universal Biosensors Inc.
For more information about this report visit https://www.researchandmarkets.com/r/wrs9b4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
